Skip to content

Cellaïon

In liquidation since 03-06-2024 Public limited companyfounded 2021Rue Granbonpré 11, 1435 Mont-Saint-GuibertKBO/BCE: BE 0764.522.425
Cellaïon
Follow Report

Last board

3 directors, 2 in day-to-day management, 1 auditor, last change in 2024
Expert Service & Advice in Healthcare BV
Chair, director and managing director, permanent representative Etienne Sokal
chair appointed by deed of 04-03-2021 director appointed by deed of 02-02-2023
ALTER Cédric
Director
since 03-06-2024
listed in the 2025 annual accounts, filed on 25-07-2026
A Q INVEST BV
Director and managing director, permanent representative Alain Parthoens
appointed by deed of 04-03-2021
also on the board of 5 other companies
1 other company bankrupt
Didier Delanoye
Statutory auditor
appointed by deed of 23-02-2022
A Q INVEST, Expert Service & Advice in Healthcare
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 20: Représentation de la société 1. Tous les actes qui engagent la société, en justice et dans tous les actes, sont valables s’ils…”
deed of 04-03-2021
Permanent representatives 2
Etienne Sokal
Permanent representative, for Expert Service & Advice in Healthcare
appointed by deed of 04-03-2021
Alain Parthoens
Permanent representative, for A Q INVEST
appointed by deed of 04-03-2021

Office holders in the KBO →

Mandates through the years

19 names, the dashed line is today
Show
A Q INVEST
Director, Managing director
Expert Service & Advice in Healthcare
Chair, Managing director, Director
ALTER Cédric
Director
Didier Delanoye
Statutory auditor
James Phillips
Director
Jim Philipps
Director
Dorothea Ledergerber
Independent director
De Backer Philippe Simon
Director
Newton Biocapital II Partners SRL
Director
Tetsuya Kurihara
Director
Walid Abi-Saab
Director
Chris Buyse
Director
Fouzia Laghrissi-Thode
Director
Pouletty Philippe
Director
Poyet Claire
Director
SOCIÉTÉ D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON
Director
SPARAXIS
Director
ABDA LILLY
Director
Invest.BW SA
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • A Q INVEST
    • Director, from 25-02-2021 to 26-01-2022
    • Director, appointed by deed of 04-03-2021, still in office
    • Managing director, appointed by deed of 04-03-2021, still in office
  • Expert Service & Advice in Healthcare
    • Director, from 25-02-2021 to 02-02-2023
    • Chair, appointed by deed of 04-03-2021, still in office
    • Managing director, appointed by deed of 04-03-2021, still in office
    • Director, appointed by deed of 02-02-2023, still in office
  • ALTER Cédric
    • Director, from 03-06-2024 to date
  • Didier Delanoye
    • Statutory auditor, appointed by deed of 23-02-2022, still in office
  • James Phillips
    • Director, from 02-10-2023, no longer listed in the 2025 annual accounts
  • Jim Philipps
    • Director, appointed by deed of 08-12-2023, no longer listed in the 2025 annual accounts
  • Dorothea Ledergerber
    • Independent director, from 27-09-2023, no longer listed in the 2025 annual accounts
  • De Backer Philippe Simon
    • Director, from 29-12-2022 to 23-06-2023
  • Newton Biocapital II Partners SRL
    • Director, from 29-12-2022, no longer listed in the 2025 annual accounts
  • Tetsuya Kurihara
    • Director, from 13-06-2023, no longer listed in the 2025 annual accounts
  • Walid Abi-Saab
    • Director, from 10-05-2023, no longer listed in the 2025 annual accounts
  • Chris Buyse
    • Director, from 17-01-2022 to 02-02-2023
  • Fouzia Laghrissi-Thode
    • Director, from 14-04-2022, no longer listed in the 2025 annual accounts
  • Pouletty Philippe
    • Director, from 29-12-2022, no longer listed in the 2025 annual accounts
  • Poyet Claire
    • Director, appointed by deed of 02-02-2023, no longer listed in the 2025 annual accounts
  • SOCIÉTÉ D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON
    • Director, until 02-02-2023
  • SPARAXIS
    • Director, from 17-01-2022, no longer listed in the 2025 annual accounts
  • ABDA LILLY
    • Director, from 25-02-2021 to 26-01-2022
    • Director, appointed by deed of 04-03-2021, no longer listed in the 2025 annual accounts
  • Invest.BW SA
    • Director, from 17-01-2022, no longer listed in the 2025 annual accounts

Control

Shareholder
PROMETHERA BIOSCIENCES
Equity -€1.5m
Loss €519,541 in 2022
Checked score 10
bankrupt on 27-05-2024
19.96%
This company
Cellaïon
Equity -€13.9m
Loss €15,747 in 2025

and 4 other shareholders

Capital

Capital
€7,094,750
Shares
2,347,023
Contribution per share
€3.02
Equity per share
-€5.91 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Newton Biocapital II
9.95%16.19%16.89%
16.89%
Wallonie Entreprendre
15.57%16.24%
16.24%
Fund+
0.86%
0.86%
SOPARTEC
0.4%
0.4%
PROMETHERA BIOSCIENCES
100%19.96%
19.96% until 2022
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 02-02-2023 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 6 directors
At most 9 directors
“Si poste Investisseur Additionnel non occupé,assemblée à majorité simple peut mais non obligée nommer administrateur indépendant additionnel…”
deed of 23-06-2023 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moyenne ponderee prix par action payes 12 mois precedents, chaque autre actionnaire transfere toutes actions et prets subordonnes le cas…”
“Fin Période d’inaliénabilité, Nouveaux Investisseurs peuvent exiger des Dragged Parties transfert de toutes actions et autres titres et…”
“Fin Période d’inaliénabilité, offre contraignante de bonne foi d’un tiers Candidat Acheteur à des actionnaires pour toutes les actions”
deed of 02-02-2023 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of May at 14:00
deed of 02-02-2023 (in French)

Shareholders

5 owners

Owners 5

Capital transactions

Shareholders according to the deeds
At incorporation deed of 04-03-2021 ↗
Capital over time
  1. 02-04-2024 Capital stated in the deed · €7,094,750.27 · 2,347,023 shares
  2. 25-01-2024 Capital stated in the deed · €7,091,983.26 · 963,516 shares
  3. 09-10-2023 Capital reduction of €15,038,521 · to €6,581,793.02
  4. 09-10-2023 Capital increase of €508,786 · to €7,090,579.02 · 5,087 new shares · in cash
  5. 23-06-2023 Capital increase of €5,533,714 · to €21,620,314.02 · 55,336 new shares at €100 per share · in cash
  6. 02-02-2023 Capital increase of €8,000,100 · to €16,086,600.01 · 80,001 new shares · in cash
  7. 02-02-2023 Capital increase of €0.01 · 13,438 new shares
  8. 26-01-2022 Capital increase of €5,210,249.98 · to €5,371,749.98 · 52,102 new shares · in cash
Show 2 older capital entries
  1. 26-01-2022 Capital increase of €2,814,750.02 · to €8,086,500 · 28,648 new shares · in kind
  2. 04-03-2021 Incorporation · €61,500 · 615 shares

The directors' other companies

1 last director with another company that went bankrupt, was dissolved or struck off

1 other company of this director went bankrupt (2024).

Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.

Next steps

See who ran this company and where its registered office was, on a date of your choice.Company as of a date See what became of the directors' other companies.Supplier due diligence

We would like to set cookies. That happens only with your consent. What we measure